ClinicalTrials.Veeva

Menu

Neuro-ultrasound Assessment in Behcet's Disease

A

Assiut University

Status

Unknown

Conditions

Behcet Syndrome

Treatments

Diagnostic Test: ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT04738864
17300548

Details and patient eligibility

About

Assessment of structural changes that occur in large extracranial and intracranial arteries in patients with Behcet's disease

Full description

Patients will be selected from Rheumatology and Rehabilitation inpatient and outpatient clinics in Assiute University Hospital Patients under 16 years old, patients with hyperlipidemia, hypertension, diabetes mellitus and all other risk factors affecting blood vessel intimal thickness will be excluded from the research.

All patients and control groups underwent a complete extracranial and intracranial ultrasound assessment by 2 experienced neurovascular sonographers .The ultrasound examination was done at the Neurovascular Ultrasound Laboratory in the Neurology department, Assiut University hospitals using a color-coded duplex ultrasound device Philips HD5 (Philips Medical Systems, Nederland B.V.) for the carotid and vertebral arteries and for the intracranial arteries.

Intimal medial thickness (IMT) of the common carotid artery (CCA), peak systolic velocities (PSVs) and end diastolic velocities (EDVs) were measured in the common, internal, and external carotid arteries (CCA, ICA, ECA) with L 3-12 MHz linear transducer probe and when stenosis was detected the velocities were measured at the maximally stenotic area.

The intracranial arteries were evaluated in all patients with transcranial color-coded duplexsonography (TCCS) with the use of a low-frequency (2- to 5-MHz) phased-array probe through the transtemporal acoustic bone window. The middle cerebral artery (MCA), intracranial segment of vertebral artery (V4)and basilar artery (BA) were examined. Peak systolic velocity (PSV) and flow direction (antegrade or reversed) used for the diagnosis of any intracranial atherosclerotic disease (ICAD).

The findings and the atherosclerotic changes in the extracranial and intracranial vessels were interpreted according to the internationally published data Data will be analyzed using the computer program SPSS

Enrollment

30 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patient more than 18 years old
  • All patients fulfill the modified International Criteria for Behçet's Disease

Exclusion criteria

  • Patients under 16 years old,
  • patients with hyperlipidemia, hypertension, diabetes mellitus and all other risk factors affecting blood vessel intimal thickness

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

behcet's disease patient
Experimental group
Description:
patient who presented with manifestation of behcet disease
Treatment:
Diagnostic Test: ultrasound
Healthy people
Experimental group
Description:
healthy control people
Treatment:
Diagnostic Test: ultrasound

Trial contacts and locations

1

Loading...

Central trial contact

Shady M Safwat, Lecturer; Esraa A Talaat, lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems